A DRUG dubbed the “new thalidomide” will face stronger restrictions from January, regulators have announced. Valproate — an epilepsy drug that has been linked to birth defects — will no longer be offered to new patients under 55 unless no other treatment is effective. AlamyValproate – dubbed the ‘new thalidomide; – will face stronger restrictions from January[/caption] The Medicines & Healthcare products Regulatory Agency announced the changes, with new prescriptions only to be offered if two doctors sign off on them or “reproductive risks do not apply”. It is the first time the drug has been restricted for men and boys, who could have their fertility impacted by it, research sh
Hence then, the article about new rules over drug dubbed new thalidomide after medication shown to cause birth defects in babies was published today ( ) and is available onThe U.S. Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( New rules over drug dubbed ‘new thalidomide’ after medication shown to cause birth defects in babies )